Literature DB >> 16175135

Stabilizing drug molecules in biological samples.

Jiwen Chen1, Yunsheng Hsieh.   

Abstract

Stability is one of the basic parameters, along with accuracy, precision, selectivity, and sensitivity, for bioanalytic method validation in nonhuman and clinical pharmacology/toxicology, bioavailability (BA), bioequivalence (BE), and other studies related to the drug approval process. In the drug development stage where stability evaluation is obligatory, instability of drug candidates in biologic samples will seriously complicate assay validation. In this article, we review the general strategies and methodologies such as temperature adjustment, pH control, derivatization, and addition of inhibitors and oxidant that are commonly employed to stabilize pharmaceuticals that might be unstable in biologic samples.

Mesh:

Substances:

Year:  2005        PMID: 16175135     DOI: 10.1097/01.ftd.0000170879.18139.40

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  5 in total

1.  Degradation of zopiclone during storage of spiked and authentic whole blood and matching dried blood spots.

Authors:  Ricarda Jantos; Annemiek Vermeeren; Danica Sabljic; Johannes G Ramaekers; Gisela Skopp
Journal:  Int J Legal Med       Date:  2012-04-25       Impact factor: 2.686

2.  Heat stabilization of blood spot samples for determination of metabolically unstable drug compounds.

Authors:  Daniel Blessborn; Karl Sköld; David Zeeberg; Karnrawee Kaewkhao; Olof Sköld; Martin Ahnoff
Journal:  Bioanalysis       Date:  2013-01       Impact factor: 2.681

3.  Pre-analytic evaluation of volumetric absorptive microsampling and integration in a mass spectrometry-based metabolomics workflow.

Authors:  Chiara Volani; Giulia Caprioli; Giovanni Calderisi; Baldur B Sigurdsson; Johannes Rainer; Ivo Gentilini; Andrew A Hicks; Peter P Pramstaller; Guenter Weiss; Sigurdur V Smarason; Giuseppe Paglia
Journal:  Anal Bioanal Chem       Date:  2017-08-17       Impact factor: 4.142

4.  Development and Validation of a Sensitive and Specific LC-MS/MS Method for IWR-1-Endo, a Wnt Signaling Inhibitor: Application to a Cerebral Microdialysis Study.

Authors:  Sreenath Nair; Abigail Davis; Olivia Campagne; John D Schuetz; Clinton F Stewart
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

5.  A feasibility study prior to an international multicentre paediatric study to assess pharmacokinetic/pharmacodynamic sampling and sample preparation procedures, logistics and bioanalysis.

Authors:  Agnes Maria Ciplea; Stephanie Laeer; Bjoern Bengt Burckhardt
Journal:  Contemp Clin Trials Commun       Date:  2018-08-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.